Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Conscience: A Brief History.
Journal: The New bioethics : a multidisciplinary journal of biotechnology and the body
Published: September 03, 2025
Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma.
Journal: Case reports in critical care
Published: August 23, 2022
ASCO Voices 2020.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2020
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.
Journal: Journal of gastrointestinal oncology
Published: October 12, 2019
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 26, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Journal: Breast cancer research and treatment
Published: February 02, 2018
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Journal: Cancer discovery
Published: January 29, 2018
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 30, 2016
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Journal: Cancer discovery
Published: March 11, 2015
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Journal: The oncologist
Published: January 03, 2012
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
Journal: Cancer chemotherapy and pharmacology
Published: November 02, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026